ranolazine
Selected indexed studies
- Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. (Br J Cancer, 2024) [PMID:38424164]
- Ranolazine: A Contemporary Review. (J Am Heart Assoc, 2016) [PMID:26979079]
- Ranolazine in Cardiac Arrhythmia. (Clin Cardiol, 2016) [PMID:26459200]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. (2024) pubmed
- Ranolazine: A Contemporary Review. (2016) pubmed
- Ranolazine in Cardiac Arrhythmia. (2016) pubmed
- Ranolazine and its Antiarrhythmic Actions. (2015) pubmed
- Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence. (2025) pubmed
- Ranolazine Therapy in Cardiac Arrhythmias. (2016) pubmed
- Ranolazine for stable angina pectoris. (2017) pubmed
- The Role of Ranolazine in Heart Failure-Current Concepts. (2023) pubmed
- Role of ranolazine in heart failure: From cellular to clinic perspective. (2022) pubmed
- Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction. (2021) pubmed